4-N-(1H-indazol-4-yl)-2-N-[3-(2-methylpropylamino)sulfanylphenyl]pyrimidine-2,4-diamine
C21H23N7S — CID 143348184
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-N-(1H-indazol-4-yl)-2-N-[3-(2-methylpropylamino)sulfanylphenyl]pyrimidine-2,4-diamine
4-N-(1H-indazol-4-yl)-2-N-[3-(2-methylpropylamino)sulfanylphenyl]pyrimidine-2,4-diamine (PubChem CID 143348184) has the molecular formula C21H23N7S and a molecular weight of 405.53 g/mol. Its IUPAC name is 4-N-(1H-indazol-4-yl)-2-N-[3-(2-methylpropylamino)sulfanylphenyl]pyrimidine-2,4-diamine.
Molecular Properties
| Compound Name | 4-N-(1H-indazol-4-yl)-2-N-[3-(2-methylpropylamino)sulfanylphenyl]pyrimidine-2,4-diamine |
|---|---|
| PubChem CID | 143348184 |
| Molecular Formula | C21H23N7S |
| Molecular Weight | 405.53 g/mol |
| Exact Mass | 405.17 |
| IUPAC Name | 4-N-(1H-indazol-4-yl)-2-N-[3-(2-methylpropylamino)sulfanylphenyl]pyrimidine-2,4-diamine |
| SMILES | CC(C)CNSc1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1 |
| InChI | InChI=1S/C21H23N7S/c1-14(2)12-24-29-16-6-3-5-15(11-16)25-21-22-10-9-20(27-21)26-18-7-4-8-19-17(18)13-23-28-19/h3-11,13-14,24H,12H2,1-2H3,(H,23,28)(H2,22,25,26,27) |
| InChIKey | SQAGLECNGKMUEC-UHFFFAOYSA-N |
| XLogP | 5.09 |
| TPSA | 90.55 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 405.53 |
| LogP ≤ 5 | 5.09 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'sulphur_nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143348184 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.